Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Rare Case of Essential Thrombocythemia with Coexisting JAK2 and MPL Driver Mutations.

Journal of Korean medical science - 15 Jun 2020

Jang Mi Ae, Seo Mi Yeon, Choi Kyoung Jin, Hong Dae Sik

Abstract excerpt

Philadelphia-negative (Ph-) classical myeloproliferative neoplasms (MPNs) include polycythemia vera, essential thrombocythemia (ET), and primary myelofibrosis. Somatic driver mutations in the JAK2, CALR, and MPL genes serve as major diagnostic criteria of the Ph- MPNs and these mutations occur in a mutually exclusive manner. In this report, we describe the first case of ET harboring double mutations in JAK2 V617F...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to Bone Marrow
Share to Janus Kinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Phenotype

Share to Receptors, Thrombopoietin

Share to Thrombocythemia, Essential

Source

Open in PubMed Open full text

Identifiers

PMID: 32537949
DOI: 10.3346/jkms.2020.35.e168
PMCID: PMC7295601

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Rare Case of Essential Thrombocythemia with Coexisting JAK2 and MPL Driver Mutations.PMID 32537949Read ↗

Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL.Semantic proximity Read ↗

Non-MPL-W515K/L mutations in myeloproliferative neoplasms: Insights from two case reports and a review of the literature.Semantic proximity Read ↗

Primary myelofibrosis with concurrent MPL and atypical JAK2 mutations.Semantic proximity Read ↗

[Clinical Analysis of Driver Mutations in Patients with Ph Negative Myeloproliferative Neoplasms].Semantic proximity Read ↗

CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable.Semantic proximity Read ↗

Clinical and biological characterization of MPN patients harboring two driver mutations, a F rench intergroup of myeloproliferative neoplasms (FIM) studySemantic proximity Read ↗

JAK2, CALR, and MPL mutation spectrum in Japanese patients with myeloproliferative neoplasmsSemantic proximity Read ↗

Mutational subtypes of JAK2 and CALR correlate with different clinical features in Japanese patients with myeloproliferative neoplasms.Semantic proximity Read ↗

Genetic basis and molecular profiling in myeloproliferative neoplasms.Semantic proximity Read ↗

Clonal Hematopoiesis and Mutations of Myeloproliferative NeoplasmsSemantic proximity Read ↗

Molecular and genetic bases of myeloproliferative disorders: questions and perspectives.Semantic proximity Read ↗

Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.